09 August 2018
Visiongain has launched a new pharma report Global Next Generation Multi-Purpose Biosensors Market 2017-2027 : Nanomechanical, Optical, Electrochemical, Thermistor/Calorimetric, Patient Monitoring, Diagnostics, Therapeutics, Wearable, Implantable, Strip, Hospitals & Clinics, Home Diagnostics, Diagnostic Centres, Research Laboratories
Over the years, the next-generation multi-purpose biosensors market has witnessed a high adoption rate for advanced biosensors. This is due to the technological breakthroughs in the biosensors field such as the development of molecular markers, nanotechnology, microfluidics, and others. Moreover, the growing demand for cost-efficient, disposable and user-friendly devices has provided momentum for the growth of the next generation multi-purpose biosensors market.
The lead analyst of the report commented “The need for better diagnosis and treatment as well as the need to curb the cost of healthcare have led to the advent of next-generation multi-purpose biosensors. The advancements in nano and micro fabrication techniques have increased the use of next generation multi-purpose biosensors in healthcare. With features such as low cost, easy to use, and accurate results, these medical biosensors are the preferred options among patients and healthcare professionals. Therefore, many key players are involved in the development and commercialization of next generation multi-purpose biosensors.”
Leading companies featured in the report include Koninklijke Philips N.V., Abbott Laboratories, Universal Biosensors Inc., Bayer Healthcare AG, GE Healthcare, Biosensors International Group. Ltd., Medtronic plc, Nova Biomedical Corporation, Bio-Rad Laboratories Inc. and Sphere Medical Holding plc
Notes for Editors
If you are interested in a more detailed overview of this report, please send an e-mail to firstname.lastname@example.org or call her on +44 (0) 207 336 6100
Visiongain is one of the fastest-growing and most innovative independent media companies in Europe. Based in London, UK, visiongain produces a host of business-to-business reports cusing on the automotive, aviation, chemicals, cyber, defence, energy, food & drink, materials, packaging, pharmaceutical and utilities sectors.
Visiongain publishes reports produced by analysts who are qualified experts in their field. Visiongain has firmly established itself as the first port of call for the business professional who needs independent, high-quality, original material to rely and depend on.
We predict strong revenue growth through to 2031. Our work identifies which organizations hold the greatest potential. Discover their capabilities, progress, and commercial prospects, helping you stay ahead.
29 July 2021
Over the last few years, Direct-to-Patient has gained widespread attention. DTP companies offer their customers, who are patients, in this case, all kinds of services.
21 July 2021
Rising geriatric population, increasing prevalence of chronic and infectious diseases, escalating investment in drug R&D by biopharmaceutical companies, rising demand for advanced drug delivery technologies for chronic treatment are some of the major factors that drive the growth of the global drug delivery technologies market.
20 July 2021
Pharma services companies are widening their service offerings (either organically or inorganically through M&A) to become full-service providers, simplifying their customers’ operations and gaining the maximum share of their outsourcing budgets, driven by the willingness of pharma to reduce the number of outsourcers they use.